Coronavirus LIVE: India cases at 10,141,215; global death toll 1,740,762

By | December 24, 2020

Covaxin, a Covid-19 vaccine being developed by Bharat Biotech, showed long-term antibody and T- cell (immune) memory responses three months after the shot in Phase-I volunteers and tolerable safety outcomes in Phase-II study, the company said, suggesting the antibodies might persist for six to 12 months.


In Phase-II, it also showed enhanced humoral and cell- mediated immune responses and the results were found in the safety and immunogenicity clinical trial of the vaccine candidate.


World update: The global tally of coronavirus cases stands at 79,253,882. While 55,835,381 have recovered, 1,741,357 have died so far. The US, the worst-hit country, has 18,923,903 cases, and 334,129 have died from the disease there. It is followed by India, which has 10,123,544 cases, Brazil (7,366,677), Russia (2,963,688), France (2,505,875).

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *